Skip to search formSkip to main contentSkip to account menu

DHP 218

Known as: DHP-218 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

DihydropyridinesOrganophosphorus Compounds

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
arylideneacetonylphosphonates (7) were allowed to react with the appropriate 3-aminocro- tonates (8) in 2-propanol under reflux to afford the 1,4-dihydropyridines (II) in 10-86% yields. The 1…
A series of 1,4-dihydropyridine-5-cyclic phosphonate derivatives, designed as analogues of 1,4dihydropyridine-3,5-dicarboxylate… 
1990
1990
Pre-pilot Study of Calcium Antagonist DHP-218 in Patients with Essential Hypertension
The relationship between the plasma concentration and the hypotensive effect of DHP-218 after a single oral administration was… 
1986
1986
Antihypertensive effects of a new dihydropyridine calcium antagonist.
Methyl 2,6-dimethyl-4-(2-nitrophenyl)-5-(2-oxo-1,3,2-dioxaphosphorinan-2 -yl)-1,4-dihydropyridine-3-carboxylate (DHP-218) is a… 
1986
1986
Cardiovascular effects of a new dihydropyridine calcium antagonist.
The effects of methyl 2,6-dimethyl-4-(2-nitrophenyl)-5-(2-oxo- 1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydropyridine-3-carboxylate… 
1986
1986
Effects of a new dihydropyridine calcium antagonist on vascular smooth muscles, cardiac muscles and [3H]-nitrendipine binding.
The effects of methyl 2,6-dimethyl-4-(2-nitrophenyl)-5-(2-oxo-1,3,2-dioxaphosphorinan-2- yl)-1,4- dihydropyridine 3-carboxylate… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)